NCT02543801View on ClinicalTrials.gov

A Clinical Trial of Two Periarticular Multimodal Drug Injections in Total Hip and Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

January 25, 2016

Primary Completion Date

August 21, 2018

Study Completion Date

August 21, 2018

Conditions
Total Hip and Knee Arthroplasty
Interventions
DRUG

Liposomal Bupivacaine

Periarticular injection

DRUG

Ropivacaine

Periarticular injection

DRUG

Bupivacaine

Included as an element of the Liposomal bupivacaine intervention periarticular injection

DRUG

Clonidine

Included as an element of both interventions as a standard of care periarticular injection

DRUG

Ketorolac

Included as an element of both interventions as a standard of care periarticular injection

DRUG

Epinephrine

Included as an element of both interventions as a standard of care periarticular injection

Sponsors

Lead Sponsor

Kootenai Health
All Listed Sponsors
lead

Kootenai Health

OTHER